Jun 27, 2022 06:44 PM (GMT+8) · EqualOcean
Kangtai biological announced that the application for clinical trial of tetravalent influenza virus split vaccine developed by the company has been accepted by the State Food and drug administration. Within 60 days from the date of acceptance, if no negative or questioning opinions are received from the drug trial center, the company may carry out clinical trials in accordance with the submitted scheme.

This text is a result of machine translation.